Satellite Symposia
28th Congress of ECTRIMS, 10 - 13 October 2012, Lyon, FR
Wednesday, 10 October 2012
17.15 – 18.15
Amphitheatre
Get on track, stay on track: patient journeys in MS
Merck Serono S.A.

18.30 – 19.30
Amphitheatre
Growing global experience with once-daily oral fingolimod in MS
Novartis Pharma AG

Thursday, 11 October 2012
12.45 – 13.45
Amphitheatre
MS Pathophysiology and Implications for Treatment
Genzyme

18.00 – 19.00
Auditorium Lumière
"MS spasticity symptoms management.
Endocannabinoid system modulator data beyond clinical trials"
Almirall

19.15 – 20.15
Amphitheatre
"New Concepts in MS Pathology shed light on MS treatment approaches"
Teva

Friday, 12 October 2012
12.45 – 13.45
Forum 2&3
Novel performance measures for early and long-term gains
Bayer HealthCare Pharmaceuticals

18.00 – 19.00
Amphitheatre
“Committed to MS”
Biogen Idec

